Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$12.05

$1.08 B

0.29%

$0.03

1.16%

Vitals

YTD Return

-17.6%

1 yr return

3.9%

3 Yr Avg Return

14.3%

5 Yr Avg Return

11.8%

Net Assets

$1.08 B

Holdings in Top 10

55.1%

52 WEEK LOW AND HIGH

$12.2
$11.83
$15.55

Expenses

OPERATING FEES

Expense Ratio 1.16%

SALES FEES

Front Load 5.25%

Deferred Load N/A

TRADING FEES

Turnover 32.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$12.05

$1.08 B

0.29%

$0.03

1.16%

ETHSX - Profile

Distributions

  • YTD Total Return -17.6%
  • 3 Yr Annualized Total Return 12.3%
  • 5 Yr Annualized Total Return 10.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.30%
DIVIDENDS
  • Dividend Yield 0.3%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Eaton Vance Worldwide Health Sciences Fund
  • Fund Family Name
    Eaton Vance
  • Inception Date
    Jul 26, 1985
  • Shares Outstanding
    57392692
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Jason Kritzer

Fund Description

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.


ETHSX - Performance

Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD -17.6% -41.2% 25.3% 47.87%
1 Yr 3.9% -60.2% 11.7% 11.11%
3 Yr 14.3%* -10.0% 19.7% 21.09%
5 Yr 11.8%* -6.4% 16.9% 16.08%
10 Yr 13.7%* 6.4% 18.5% 51.59%

* Annualized

Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2021 12.3% -79.9% 24.2% 15.79%
2020 5.2% -13.6% 178.2% 83.75%
2019 19.3% 3.8% 63.8% 65.03%
2018 0.8% -49.7% 21.5% 15.33%
2017 13.1% -59.8% 54.4% 67.41%

Total Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD -17.6% -46.5% 25.3% 42.55%
1 Yr -1.5% -60.2% 28.3% 29.63%
3 Yr 12.3%* -13.2% 20.0% 43.48%
5 Yr 10.6%* -6.4% 16.9% 36.94%
10 Yr 13.1%* 6.4% 18.5% 61.24%

* Annualized

Total Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2021 12.3% -79.9% 24.2% 15.79%
2020 5.2% -13.6% 178.2% 83.75%
2019 19.3% 3.8% 63.8% 65.03%
2018 0.8% -49.7% 22.2% 21.90%
2017 16.2% -59.8% 54.4% 68.15%

NAV & Total Return History


ETHSX - Holdings

Concentration Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Assets 1.08 B 732 K 46.2 B 40.43%
Number of Holdings 51 21 473 71.84%
Net Assets in Top 10 603 M 2.18 K 21.6 B 33.98%
Weighting of Top 10 55.08% 12.3% 80.8% 14.08%

Top 10 Holdings

  1. Johnson & Johnson 8.74%
  2. UnitedHealth Group Inc 8.49%
  3. AbbVie Inc 6.20%
  4. Roche Holding AG 5.41%
  5. Eli Lilly and Co 5.17%
  6. AstraZeneca PLC 4.90%
  7. AstraZeneca PLC 4.90%
  8. AstraZeneca PLC 4.90%
  9. AstraZeneca PLC 4.90%
  10. AstraZeneca PLC 4.90%

Asset Allocation

Weighting Return Low Return High ETHSX % Rank
Stocks
99.55% 85.37% 106.13% 41.75%
Cash
0.32% -0.10% 9.01% 57.28%
Preferred Stocks
0.13% 0.00% 7.86% 5.83%
Other
0.00% -22.99% 3.38% 48.06%
Convertible Bonds
0.00% 0.00% 0.37% 42.72%
Bonds
0.00% 0.00% 12.39% 41.26%

Stock Sector Breakdown

Weighting Return Low Return High ETHSX % Rank
Healthcare
100.00% 59.26% 100.00% 22.82%
Utilities
0.00% 0.00% 0.00% 39.32%
Technology
0.00% 0.00% 22.69% 44.66%
Real Estate
0.00% 0.00% 7.13% 44.17%
Industrials
0.00% 0.00% 7.02% 43.69%
Financial Services
0.00% 0.00% 1.85% 53.40%
Energy
0.00% 0.00% 0.00% 39.32%
Communication Services
0.00% 0.00% 9.11% 42.72%
Consumer Defense
0.00% 0.00% 25.73% 47.09%
Consumer Cyclical
0.00% 0.00% 14.20% 42.72%
Basic Materials
0.00% 0.00% 14.83% 58.25%

Stock Geographic Breakdown

Weighting Return Low Return High ETHSX % Rank
US
71.69% 53.67% 104.41% 89.81%
Non US
27.86% 0.00% 45.40% 8.25%

ETHSX - Expenses

Operational Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.16% 0.08% 3.13% 29.19%
Management Fee 0.78% 0.00% 1.25% 70.21%
12b-1 Fee 0.25% 0.00% 1.00% 40.91%
Administrative Fee 0.15% 0.03% 0.25% 57.89%

Sales Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.25% 0.00% 5.75% 37.50%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 32.00% 0.00% 238.00% 30.67%

ETHSX - Distributions

Dividend Yield Analysis

ETHSX Category Low Category High ETHSX % Rank
Dividend Yield 0.29% 0.00% 9.45% 48.82%

Dividend Distribution Analysis

ETHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Semi-Annually

Net Income Ratio Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Income Ratio 0.30% -2.54% 1.92% 21.97%

Capital Gain Distribution Analysis

ETHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Semi-Annually

Dividend Payout History

View More +

ETHSX - Fund Manager Analysis

Managers

Jason Kritzer


Start Date

Tenure

Tenure Rank

Jul 01, 2016

5.92

5.9%

Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.

Samantha Pandolfi


Start Date

Tenure

Tenure Rank

Jul 01, 2016

5.92

5.9%

Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.54 2.12